NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Short Interest Down 17.3% in June

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Free Report) saw a significant decline in short interest in June. As of June 15th, there was short interest totalling 8,100 shares, a decline of 17.3% from the May 31st total of 9,800 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume […]

Leave a Reply

Your email address will not be published.

Previous post Datametrex AI (CVE:DM) Sets New 1-Year Low at $0.01
Next post Examining the Costs of Making PCBs: A Worldwide Near Investigation